127791-54-2 Usage
Description
(E)-3-(3,5-dihydroxyphenyl)acrylic acid, also known as caffeic acid, is a naturally occurring organic compound that is found in a variety of plants, such as coffee, fruits, and vegetables. It belongs to the class of hydroxycinnamic acids and is recognized for its potent antioxidant properties and potential health benefits. Caffeic acid has been the subject of research due to its potential anti-inflammatory, antiviral, and anticancer properties, as well as its possible role in the prevention and management of conditions like diabetes and cardiovascular disease.
Uses
Used in Pharmaceutical Applications:
(E)-3-(3,5-dihydroxyphenyl)acrylic acid is used as a pharmaceutical agent for its potential anti-inflammatory properties, which can help in reducing inflammation and pain associated with various conditions.
Used in Antiviral Applications:
In the field of antiviral research, (E)-3-(3,5-dihydroxyphenyl)acrylic acid is used as an antiviral agent to inhibit the replication and spread of certain viruses, potentially offering a therapeutic approach to viral infections.
Used in Anticancer Applications:
(E)-3-(3,5-dihydroxyphenyl)acrylic acid is used as an anticancer agent, where it may contribute to the inhibition of cancer cell growth and the modulation of cancer-related signaling pathways, thus offering a potential therapeutic strategy in cancer treatment.
Used in Nutraceutical Applications:
As a nutraceutical, (E)-3-(3,5-dihydroxyphenyl)acrylic acid is used as a dietary supplement for its antioxidant and potential health-promoting properties, supporting overall health and well-being.
Used in Food Industry:
In the food industry, (E)-3-(3,5-dihydroxyphenyl)acrylic acid is used as a natural preservative and flavor enhancer due to its antioxidant properties, which can help extend the shelf life of various food products and improve their taste.
Used in Cosmetic Applications:
(E)-3-(3,5-dihydroxyphenyl)acrylic acid is used in the cosmetic industry for its antioxidant and anti-inflammatory properties, which can be beneficial in skincare products for promoting healthy and radiant skin.
Check Digit Verification of cas no
The CAS Registry Mumber 127791-54-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,7,7,9 and 1 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 127791-54:
(8*1)+(7*2)+(6*7)+(5*7)+(4*9)+(3*1)+(2*5)+(1*4)=152
152 % 10 = 2
So 127791-54-2 is a valid CAS Registry Number.
127791-54-2Relevant articles and documents
Br?nsted Acid Catalyzed Tandem Defunctionalization of Biorenewable Ferulic acid and Derivates into Bio-Catechol
Bal, Mathias,Bomon, Jeroen,Liao, Yuhe,Maes, Bert U. W.,Sels, Bert F.,Sergeyev, Sergey,Van Den Broeck, Elias,Van Speybroeck, Veronique
, p. 3063 - 3068 (2020/02/05)
An efficient conversion of biorenewable ferulic acid into bio-catechol has been developed. The transformation comprises two consecutive defunctionalizations of the substrate, that is, C?O (demethylation) and C?C (de-2-carboxyvinylation) bond cleavage, occurring in one step. The process only requires heating of ferulic acid with HCl (or H2SO4) as catalyst in pressurized hot water (250 °C, 50 bar N2). The versatility is shown on a variety of other (biorenewable) substrates yielding up to 84 % di- (catechol, resorcinol, hydroquinone) and trihydroxybenzenes (pyrogallol, hydroxyquinol), in most cases just requiring simple extraction as work-up.
Second bioluminescence-activating component in the luminous fungus Mycena chlorophos
Teranishi, Katsunori
, p. 182 - 189 (2017/03/09)
Mycena chlorophos is an oxygen-dependent bioluminescent fungus. The mechanisms underlying its light emission are unknown. A component that increased the bioluminescence intensity of the immature living gills of M. chlorophos was isolated from mature M. chlorophos gills and chemically characterized. The bioluminescence-activating component was found to be trans-3,4-dihydroxycinnamic acid and its bioluminescence activation was highly structure-specific. 13C- and 18O-labelling studies using the immature living gills showed that trans-3,4-dihydroxycinnamic acid was synthesized from trans-4-hydroxycinnamic acid in the gills by hydroxylation with molecular oxygen as well as by the general metabolism, and trans-3,4-dihydroxycinnamic acid did not produce hispidin (detection-limit concentration: 10 pmol/1 g wet gill). Addition of 0.01 mM hispidin to the immature living gills generated no bioluminescence activation. These results suggested that the prompt bioluminescence activation resulting from addition of trans-3,4-dihydroxycinnamic acid could not be attributed to the generation of hispidin. Copyright
